Seagen Inc. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for September 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 28 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 9,017 | 99,999 | 0 | |
Sep 28 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 9,017 | 99,999 | 687,146 | 678.1 K to 687.1 K (+1.33 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 17,117 | 189,828 | 207,151 | |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,715 | 19,019 | 224,268 | |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 53.42 | 17,117 | 914,390 | 678,129 | 695.2 K to 678.1 K (-2.46 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 17,117 | 189,828 | 695,246 | 678.1 K to 695.2 K (+2.52 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 54.15 | 1,715 | 92,867 | 678,129 | 679.8 K to 678.1 K (-0.25 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,715 | 19,019 | 679,844 | 678.1 K to 679.8 K (+0.25 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 12.16 | 6,836 | 83,126 | 9,831 | |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 9.23 | 3,164 | 29,204 | 0 | |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 52.72 | 3,164 | 166,806 | 164,906 | 168.1 K to 164.9 K (-1.88 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 9.23 | 3,164 | 29,204 | 168,070 | 164.9 K to 168.1 K (+1.92 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 53.45 | 6,836 | 365,384 | 164,906 | 171.7 K to 164.9 K (-3.98 %) |
Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 12.16 | 6,836 | 83,126 | 171,742 | 164.9 K to 171.7 K (+4.15 %) |
Sep 08 2017 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 52.00 | 9,638 | 501,176 | 218,377 | 228 K to 218.4 K (-4.23 %) |
Sep 08 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 15.46 | 5,024 | 77,671 | 2,268 | |
Sep 08 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 16.41 | 5,024 | 82,444 | 0 | |
Sep 08 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 51.94 | 5,024 | 260,967 | 77,230 | 82.3 K to 77.2 K (-6.11 %) |
Sep 08 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 15.46 | 5,024 | 77,671 | 82,254 | 77.2 K to 82.3 K (+6.51 %) |
Sep 08 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 16.41 | 5,024 | 82,444 | 77,230 | 72.2 K to 77.2 K (+6.96 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 25,000 | 386,500 | 18,089 | |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 52.24 | 25,000 | 1,305,893 | 117,424 | 142.4 K to 117.4 K (-17.55 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 25,000 | 386,500 | 142,424 | 117.4 K to 142.4 K (+21.29 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | M | 18.46 | 2,907 | 53,663 | 0 | |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 52.51 | 4,662 | 244,794 | 72,206 | 76.9 K to 72.2 K (-6.06 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 52.52 | 2,907 | 152,672 | 76,868 | 79.8 K to 76.9 K (-3.64 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Buy | M | 18.46 | 2,907 | 53,663 | 79,775 | 76.9 K to 79.8 K (+3.78 %) |